Former ACT Editor Back in Clinical Research
Jane Ganter, retired Editor Emeritus of Applied Clinical Trials, was inducted into the Alpha Eta Society on 21 May 2005.
Jane Ganter, retired Editor Emeritus of Applied Clinical Trials, was inducted into the Alpha Eta Society on 21 May 2005. The allied health academic honor society promotes scholarship and recognizes leadership in health care professions. Ganter is a part-time writing coach for The George Washington University's distance learning program in Clinical Research Administration. Other Health Sciences faculty members honored at the induction ceremony are Kimberly Acquaviva, Joseph Bocchino, Judith Bowes, Rozmin Jamal, and Tamara Norman. The event took place at GWU's Executive Education Center in Washington, DC.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Arcus’ Quemliclustat Earns Orphan Drug Designation as Phase III Pancreatic Cancer Trial Advances
July 11th 2025The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the global PRISM-1 Phase III trial nears full enrollment following promising survival data from ARC-8.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.
